ARGS | Blue Horseshoe Stocks

Blue Horseshoe Stocks: HMNY, SANP Review & More

Helios and Matheson Analytics, Inc. HMNY

We began tracking HMNY closely on September 20th, and since that time it’s been nothing but blue sky breakout for the stock ever since. On that morning we observed a low of 5.47, and it’s never looked back.

To kick off the week yesterday HMNY soared to an astonishing new high of 23.49, marking a 329% increase in a span of less than three weeks. Volume has also been coming in far above anything the stock saw prior to September.

Santo Mining Corp. SANP

We decided to tag SANP in yesterday morning’s premarket report after noticing the manifestation of some unusual trading activity over the course of last week. It ended up being a solid idea to start of this week, with the stock making a very convincing move to the upside.

From a low of .0013, SANP reached as high as .0021, marking an intraday push of 62%, with the better part of a billion shares changing hands on the day. It was the third consecutive session in which the stock registered higher lows and higher highs, and we’ll be in the lookout for a continuation of that pattern.

Cleantech Solutions International, Inc. CLNT

Another inclusion in yesterday’s report was CLNT, which ran pretty hard early on in the session with the help of a PR alluding to a possible acquisition (>>View PR).

The stock made a move from a low of 5.70 to a high of 8.25- a respectable 45% pop. CLNT ultimately ended up trading an incredible 330X its monthly average volume. While it didn’t maintain at least half of its daily gains into the close, with volume like that, we’ll be sure to keep a slot on our watchlists open for CLNT.

MannKind Corp. MNKD

We saw a pullback in MNKD Friday after a solid move, and we signaled some options calls, MNKD 10/20 $5.50 & $6.00, that pullback gave a great potential entry point. This morning in the premarket, MNKD is gapping up past the $6 mark, pushing the strike prices we targeted into the money.

Its always a good idea to lock in some profits on a gap up, in case a stock decides to pull back. In the event we see do a pullback in this case, we may look to take advantage of the dip by re-entering the position.

MNKD has one of our favorite chart patterns- when the 50DMA breaks above the 200DMA, known as a “Golden Cross”. Stocks tend to breakout when this occurs so we definitely want to continue to track this idea going forward.

Extended Watchlist:
OCRX, GEVO, ABEO, KALV, CVM, ARGS, USEG

Blue Horseshoe Stocks: SPY Options & More

SPDR S&P 500 ETF Trust – SPY

We’re projecting a solid day for the markets as a whole to close out the week as positive jobs numbers just hit, and usually in these cases, we like to use the SPY to get in on the action in the short term. We’re going to designate the SPY Weekly $247-248.50 Calls* as our contracts of interest.

Not only did hiring stay strong while jobless claims fell , but non-farm payroll gains exceeded expectations by a considerable margin, foreshadowing strength in US labor. To boot, the June Trade Balance figures came in and roughly $1.3B was shaved off of the expected trade deficit. All in all, these are several contributing factors that could certainly energize today’s session, and produce considerable intraday gain opportunities in our highlighted options.

______

GoPro, Inc. GPRO

While we’re thinking of potential quick-strike options plays, we’ve got to take a look at GPRO, which is gapping up in the premarket this morning on the heels of its Q2 earnings beat, and strong outlook. We’ve been familiar with GRPO options in the past, although it has been quite some time.

Prior to these bolstered figures as well as an analyst upgrade from Morgan Stanley this week, GPRO shares had been somewhat stuck in the mud for most of the summer so far. An extended rebound could be in the cards, but for now, we’ll just track today’s activity on the GPRO Weekly $9-10 Calls*.
______

*We don’t include mentions of weekly options contracts on a Friday without explicitly warning our readers every single time. Trading weekly options at the end of the week is an exceedingly risky proposition that should never be attempted by beginning or novice traders!

Extended Watchlist:
JSDA, PDLI, HDP, MTZ, SRNE, ARGS

Blue Horseshoe Stocks: Stellar Options Calls & More

Valeant Pharmaceuticals, Inc. VRX – Options Recap

In yesterday morning’s premarket report, we noted that VRX had been coming off of recent annual lows, had a beat on earnings, and was up considerably in early trading.

Our exact words were “We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.” Things did play out similarly. We did indeed see considerable gains, and quite frankly, that’s an understatement.

As VRX itself traded from 10.57 to 12.43, our targeted options calls posted astronomical moves on the day, giving traders a chance to grab a piece of the following gains:

$10.50 Calls – Range: .40-.1.92 – Max Gain: 380%
$11 Calls – Range: .18-1.50 – Max Gain: 733%
$11.50 Calls – Range: .08-1.05 – Max Gain: 1212%
$12 Calls – Range: .02-.74 – Max Gain: 3600%

This wasn’t even the first percentage gain in the thousands that we’ve rooted out in the past week. The SPY Weekly $238-50-239.50 Calls that we highlighted in Friday morning’s premarket report yielded a 4600% gainer on that day. Both of these plays serve as perfect examples of why we don’t limit our daily reports to stocks alone.

Cleantech Solutions International, Inc. CLNT

We did have a very nice play on the stock side of things as well yesterday, after we tagged CLNT in our extended watchlist. It ended up making a solid early push from a low of 4.11, and ran as high as 6.99 inside the first hour of trading.

That was good for intraday gains of up to 70% which we feel is quite good for a stock in this price range. CLNT is pulling back in premarket, but we will remain interested in possible bounce activity in the event that it holds support above yesterday’s swing low.

Proteon Therapeutics, Inc. PRTO

There’s an interesting situation unfolding with PRTO that warrants placing the stock on watch today. Despite reporting Q1 losses of $6.5M, the stock is gapping up heavily on the strength of a concurrent announcement. It pertains to the fact that the company’s investigatory treatment, vonapanitase, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA).

Whenever such FDA news hits wires the resultant activity on the chart is sure to be interesting, which is evidenced by the the fact that traders are ignoring the disappointing quarterly figures that coincided with this event. Thus we are eager to track PRTO as we head through midweek.

Extended Watchlist:
ASTI, BZUN, LBIO, AAXN, ARGS, MTBC, REXX